ANGO EBITDA Growth
Angiodynamics Inc · EBITDA Growth
ANGO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-758.43%period ending
ANGO TTM EBITDA YoY % (820.80% → -758.43%)
Year-over-year change
High-resolution chart · PNG
ANGO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -758.4348% | |
| -846.6053% | |
| -1,089.6364% | |
| -5.6928% | |
| 77.0734% | |
| 128.3431% | |
| 102.6763% | |
| 77.1136% | |
| 47.3938% | |
| 50.1828% | |
| -1,021.983% | |
| -1,004.1424% | |
| -123.1453% | |
| -14,087.5% | |
| 113.6975% | |
| 109.8931% | |
| 66.3782% | |
| 100.9488% | |
| 88.7356% | |
| 89.3667% | |
| 91.2788% | |
| 93.5331% | |
| -4,869.5218% | |
| -277,011.3208% | |
| -9,501.6129% | |
| -4,457.4515% | |
| -117.4176% | |
| -100.2182% | |
| -94.2108% | |
| -109.3411% | |
| -10.9962% | |
| 24.0907% | |
| -21.7295% | |
| -10.1169% | |
| -60.2105% | |
| -56.0169% | |
| 11.5179% | |
| 33.3547% | |
| 48.8566% | |
| 116.2262% | |
| 27.9096% | |
| 9.4083% | |
| 23.2002% | |
| -49.5725% | |
| -37.7796% | |
| -29.0684% | |
| -26.8967% | |
| 42.5493% | |
| 25.1445% | |
| 7.4814% | |
| 57.9271% | |
| 74.5079% | |
| 147.9111% | |
| 306.8703% | |
| 61.5195% | |
| -24.3406% | |
| -46.1578% | |
| -65.2426% | |
| -56.7261% | |
| -32.3582% | |
| -28.6395% | |
| -27.3935% | |
| 1.3236% | |
| 11.16% | |
| 14.9209% | |
| 16.0836% | |
| 35.0666% | |
| 5.8884% | |
| 6.58% | |
| 12.6155% | |
| -17.4178% | |
| 3,535.0567% | |
| 709.5128% | |
| 421.1873% | |
| 373.8919% | |
| -106.6544% | |
| -138.68% | |
| -168.6336% | |
| -196.3025% | |
| 20.7641% | |
| 21.9053% | |
| 33.9922% | |
| 36.228% | |
| 49.924% | |
| 307.6175% | |
| 820.8017% |